Clinical Trial Update: FCI-Glioblastoma Study

View source ↗

Summary

Clinical trial update indicates the FCI-Glioblastoma Study sponsored by the University of Aberdeen is not yet recruiting for glioblastoma (WHO Grade 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: University of Aberdeen | Conditions: Glioblastom WHO Grade 4 | Status: NOT_YET_RECRUITING